Towards Risk Stratification in Clinical Care for IgA Nephropathy: Genetic Risk Scores: Comments on the Study "Clinical Application of Polygenic Risk Score in IgA Nephropathy".
作者信息
Berthier Celine C, Ju Wenjun
机构信息
Division of Nephrology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI USA.
Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI USA.
出版信息
Phenomics. 2024 Nov 12;4(5):527-530. doi: 10.1007/s43657-024-00184-8. eCollection 2024 Oct.
Abstract
摘要
相似文献
1
Towards Risk Stratification in Clinical Care for IgA Nephropathy: Genetic Risk Scores: Comments on the Study "Clinical Application of Polygenic Risk Score in IgA Nephropathy".IgA肾病临床护理中的风险分层：遗传风险评分：对“多基因风险评分在IgA肾病中的临床应用”研究的评论
Phenomics. 2024 Nov 12;4(5):527-530. doi: 10.1007/s43657-024-00184-8. eCollection 2024 Oct.
2
Clinical use of polygenic scores in type 2 diabetes: challenges and possibilities.多基因评分在2型糖尿病中的临床应用：挑战与机遇
Diabetologia. 2025 Apr 5. doi: 10.1007/s00125-025-06419-1.
3
Machine-learning model based on ultrasomics for non-invasive evaluation of fibrosis in IgA nephropathy.基于超声组学的机器学习模型用于IgA肾病纤维化的无创评估
Eur Radiol. 2025 Jan 24. doi: 10.1007/s00330-025-11368-9.
4
Potential benefits and related treatment effects of calcineurin inhibitors combined with steroid for IgA nephropathy: a systematic review and meta-analysis.钙调磷酸酶抑制剂联合激素治疗 IgA 肾病的潜在获益及相关作用：系统评价和荟萃分析。
Int Urol Nephrol. 2023 Sep;55(9):2227-2236. doi: 10.1007/s11255-023-03524-1. Epub 2023 Mar 1.
5
Efficacy and safety of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for IgA nephropathy in children.血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂治疗儿童 IgA 肾病的疗效和安全性。
Pediatr Nephrol. 2022 Mar;37(3):499-508. doi: 10.1007/s00467-021-05316-0. Epub 2021 Oct 22.
6
Global glomerulosclerosis proportions predict nephropathy progression in IgA nephropathy: a multicenter retrospective analysis with propensity score matching.全球肾小球硬化比例可预测IgA肾病的肾病进展：一项倾向评分匹配的多中心回顾性分析
Ren Fail. 2025 Dec;47(1):2486567. doi: 10.1080/0886022X.2025.2486567. Epub 2025 May 5.
7
Identifying the potential therapeutic targets of tertiary lymphoid structure in IgA nephropathy based on bioinformatics.基于生物信息学鉴定IgA肾病中三级淋巴结构的潜在治疗靶点
Autoimmunity. 2025 Dec;58(1):2519285. doi: 10.1080/08916934.2025.2519285. Epub 2025 Jun 23.
8
Association between genetic liability to physical health conditions and comorbidities in individuals with severe mental illness: an analysis of two cross-sectional observational studies in the UK.严重精神疾病患者身体健康状况的遗传易感性与共病之间的关联：对英国两项横断面观察性研究的分析
Lancet Psychiatry. 2025 Jun;12(6):447-456. doi: 10.1016/S2215-0366(25)00123-3. Epub 2025 May 5.
9
The role of body mass index on IgA nephropathy prognosis: a systematic review and meta-analysis.体重指数对 IgA 肾病预后的作用：系统评价和荟萃分析。
Int Urol Nephrol. 2022 Oct;54(10):2567-2579. doi: 10.1007/s11255-022-03160-1. Epub 2022 Mar 12.
10
B cell-derived exosomal miR-483-5p and its potential role in promoting kidney function loss in IgA nephropathy.B细胞衍生的外泌体miR-483-5p及其在IgA肾病中促进肾功能丧失的潜在作用。
Kidney Int. 2025 Jul;108(1):119-135. doi: 10.1016/j.kint.2025.03.019. Epub 2025 Apr 22.
本文引用的文献
1
Clinical Application of Polygenic Risk Score in IgA Nephropathy.多基因风险评分在IgA肾病中的临床应用
Phenomics. 2024 Mar 21;4(2):146-157. doi: 10.1007/s43657-023-00138-6. eCollection 2024 Apr.
2
The gut microbiota posttranslationally modifies IgA1 in autoimmune glomerulonephritis.肠道微生物群在自身免疫性肾小球肾炎中对 IgA1 进行翻译后修饰。
Sci Transl Med. 2024 Mar 27;16(740):eadl6149. doi: 10.1126/scitranslmed.adl6149.
3
Time-Varying Proteinuria and Progression of IgA Nephropathy: A Cohort Study.时变蛋白尿与 IgA 肾病进展：一项队列研究。
Am J Kidney Dis. 2024 Aug;84(2):170-178.e1. doi: 10.1053/j.ajkd.2023.12.016. Epub 2024 Feb 15.
4
An Update on the Genetics of IgA Nephropathy.IgA肾病遗传学研究进展
J Clin Med. 2023 Dec 25;13(1):123. doi: 10.3390/jcm13010123.
5
IgA nephropathy.IgA 肾病。
Nat Rev Dis Primers. 2023 Nov 30;9(1):67. doi: 10.1038/s41572-023-00476-9.
6
Genome-Wide Association Analysis of Protein-Coding Variants in IgA Nephropathy.IgA 肾病中蛋白编码变异的全基因组关联分析。
J Am Soc Nephrol. 2023 Nov 1;34(11):1900-1913. doi: 10.1681/ASN.0000000000000222. Epub 2023 Oct 2.
7
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy.全基因组关联分析定义了致病性信号通路，并为 IgA 肾病确定了药物靶点。
Nat Genet. 2023 Jul;55(7):1091-1105. doi: 10.1038/s41588-023-01422-x. Epub 2023 Jun 19.
8
Genome-Wide Association Study of CKD Progression.全基因组关联研究与慢性肾脏病进展。
J Am Soc Nephrol. 2023 Sep 1;34(9):1547-1559. doi: 10.1681/ASN.0000000000000170. Epub 2023 Jun 1.
9
Omics are Getting Us Closer to Understanding IgA Nephropathy.组学研究让我们更深入地了解 IgA 肾病。
Arch Immunol Ther Exp (Warsz). 2023 Apr 15;71(1):12. doi: 10.1007/s00005-023-00677-w.
10
Long-Term Outcomes in IgA Nephropathy.IgA 肾病的长期预后。
Clin J Am Soc Nephrol. 2023 Jun 1;18(6):727-738. doi: 10.2215/CJN.0000000000000135. Epub 2023 Apr 13.
Zotero 插件